Background
migraine, Migraine, migraines
MIGRAINE, MIGRAINE, MIGRAINES
Migraine was estimated to affect more than one billion individuals worldwide in 2019 [Among individuals affected by migraines, around one-third (34–39%) may be candidates for preventive therapy [Calcitonin gene-related peptide (CGRP) has a key pathophysiological role in migraine and is expressed widely in the central and peripheral nociceptive system [Galcanezumab has been assessed in multiple phase 3 placebo-controlled trials for episodic, chronic, and treatment resistant migraine [